Dataset Information


Development of Neuroregenerative Gene Therapy to Reverse Glial Scar Tissue Back to Neuron-Enriched Tissue.

ABSTRACT: Injuries in the central nervous system (CNS) often causes neuronal loss and glial scar formation. We have recently demonstrated NeuroD1-mediated direct conversion of reactive glial cells into functional neurons in adult mouse brains. Here, we further investigate whether such direct glia-to-neuron conversion technology can reverse glial scar back to neural tissue in a severe stab injury model of the mouse cortex. Using an adeno-associated virus (AAV)-based gene therapy approach, we ectopically expressed a single neural transcription factor NeuroD1 in reactive astrocytes in the injured areas. We discovered that the reactive astrocytes were efficiently converted into neurons both before and after glial scar formation, and the remaining astrocytes proliferated to repopulate themselves. The astrocyte-converted neurons were highly functional, capable of firing action potentials and establishing synaptic connections with other neurons. Unexpectedly, the expression of NeuroD1 in reactive astrocytes resulted in a significant reduction of toxic A1 astrocytes, together with a significant decrease of reactive microglia and neuroinflammation. Furthermore, accompanying the regeneration of new neurons and repopulation of new astrocytes, new blood vessels emerged and blood-brain-barrier (BBB) was restored. These results demonstrate an innovative neuroregenerative gene therapy that can directly reverse glial scar back to neural tissue, opening a new avenue for brain repair after injury.


PROVIDER: S-EPMC7674596 | BioStudies | 2020-01-01

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC3967760 | BioStudies
| S-EPMC4675726 | BioStudies
2020-01-01 | S-EPMC7793709 | BioStudies
| S-EPMC6905344 | BioStudies
1000-01-01 | S-EPMC5470076 | BioStudies
1000-01-01 | S-EPMC6113216 | BioStudies
2013-01-01 | S-EPMC3631379 | BioStudies
2014-01-01 | S-EPMC3966078 | BioStudies
2016-01-01 | S-EPMC4763245 | BioStudies
2019-01-01 | S-EPMC6380212 | BioStudies